Literature DB >> 6286023

Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.

R L Jones, V Peesapati, N H Wilson.   

Abstract

1 The thromboxane-sensitive contractile systems in spirally-cut preparations of the rabbit aorta, dog saphenous vein and guinea-pig trachea have been compared. The full or partial agonist activities of a range of bicyclic ring analogues were found to be remarkably similar on the three preparations. In addition, EP 045, a prostanoid with a phenylsemicarbazone omega-chain, blocked the action of both thromboxane A(2) (TXA(2)) and the bicyclic ring analogues. Using 11,9-epoxymethano prostaglandin H(2) as the agonist, linear Schild plots with slopes close to unity were obtained on each preparation; this suggests a competitive type of antagonism.2 Analogues of prostaglandin D(2) (PGD(2)), PGE(2) and PGF(2alpha) also contracted the three smooth muscle preparations; those analogues containing a 16-p-halophenoxy residue were highly active. On the rabbit aorta, EP 045 completely blocked the contractile actions of these agonists, perhaps indicating a single type of prostanoid receptor in this tissue. On the dog saphenous vein PGD(2), PGE(2) and 15-methyl PGE(2) exhibited relaxant activity when the tissue was partially contracted with either a thromboxane agonist or noradrenaline. On the guinea-pig trachea 16,16-dimethyl PGE(2) and the 16-p-chlorophenoxy analogue of PGE(2) were potent contractile agents whose action was not blocked by EP 045. PGE(2) and 15-methyl PGE(2) showed similar properties but exhibited relaxant activity with increasing concentrations in the organ bath. Our results indicate the presence of three types of prostanoid receptors in the guinea-pig trachea: thromboxane- and PGE-sensitive systems mediating contraction and a PGE-sensitive system mediating relaxation.3 The similarity of the thromboxane-sensitive systems in the three smooth muscle preparations is discussed with particular reference to the differences in the equilibrium dissociation constants for EP 045.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286023      PMCID: PMC2071809          DOI: 10.1111/j.1476-5381.1982.tb09236.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Cardiovascular actions of prostaglandins D and E in the sheep: evidence for two distinct receptors.

Authors:  R L Jones
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

2.  Thromboxane A2: effects on airway and vascular smooth muscle.

Authors:  J Svenssen; K Strandberg; T Tuvemo; M Hamberg
Journal:  Prostaglandins       Date:  1977-09

3.  A direct,stereocontrolled total synthesis of the 9,11-azo analogue of the prostaglandin endoperoxide, PGH2.

Authors:  E J Corey; K Narasaka; M Shibasaki
Journal:  J Am Chem Soc       Date:  1976-09-29       Impact factor: 15.419

4.  The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.

Authors:  B Samuelsson; M Hamberg; C Malmsten; J Svensson
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

5.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.

Authors:  P Needleman; S Moncada; S Bunting; J R Vane; M Hamberg; B Samuelsson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

6.  The use of the in vivo trachea preparation of the guinea-pig to asses drug action on lung.

Authors:  G W James
Journal:  J Pharm Pharmacol       Date:  1969-06       Impact factor: 3.765

7.  Straight phase separation of prostaglandin methyl esters on lipophilic gels.

Authors:  A R Brash; R L Jones
Journal:  Prostaglandins       Date:  1974-03-10

8.  Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220.

Authors:  J B Farmer; D G Farrar; J Wilson
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

9.  Prostaglandin d2 as a potential antithrombotic agent.

Authors:  E E Nishizawa; W L Miller; R R Gorman; G L Bundy; J Svensson; M Hamberg
Journal:  Prostaglandins       Date:  1975-01

10.  On the formation and effects of thromboxane A2 in human platelets.

Authors:  J Svensson; M Hamberg; B Samuelsson
Journal:  Acta Physiol Scand       Date:  1976-11
View more
  38 in total

1.  Cerebrovascular effects of prostanoids. In-situ studies in pial arteries of the cat.

Authors:  M Wahl; L Schilling; E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

2.  A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.

Authors:  H Giles; M L Bolofo; S J Lydford; G R Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.

Authors:  Y J Dong; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.

Authors:  S Hamid-Bloomfield; A N Payne; A A Petrovic; B J Whittle
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  The pharmacological properties of the peptide, endothelin.

Authors:  R M Eglen; A D Michel; N A Sharif; S R Swank; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung.

Authors:  R Carrier; E J Cragoe; D Ethier; A W Ford-Hutchinson; Y Girard; R A Hall; P Hamel; J Rokach; N N Share; C A Stone
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

Review 7.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

8.  Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.

Authors:  S Narumiya; M Okuma; F Ushikubi
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

9.  Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations.

Authors:  X Norel; C Labat; P J Gardiner; C Brink
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

10.  Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

Authors:  W K Pollock; R A Armstrong; L J Brydon; R L Jones; D E MacIntyre
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.